CRYO-CELL INTERNATIONAL, INC. Interest Expense Nonoperating
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Interest Expense Nonoperating of $441.92 thousand for the 3-month period ending 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-07-15
- CRYO-CELL INTERNATIONAL, INC. interest expense nonoperating for the quarter ending 2026-05-31 was $441.92K, a 19.82% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. interest expense nonoperating for the quarter ending 2026-02-28 was $462.71K, a 6.52% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. interest expense nonoperating for the quarter ending 2025-11-30 was $481.95K, a 35.35% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. interest expense nonoperating for the quarter ending 2025-08-31 was $538.22K, a 0.89% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. interest expense nonoperating for fiscal 2025 was $2.07M, a 10.81% increase from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. interest expense nonoperating for fiscal 2024 was $1.86M, a 50.77% increase from fiscal 2023.
- CRYO-CELL INTERNATIONAL, INC. interest expense nonoperating for fiscal 2023 was $1.24M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-05-31 | $441.92K 10-Q · filed 2026-07-15 | $904.63K 10-Q · filed 2026-07-15 | $1.39M derived: sum of 3 quarters · filed 2026-07-15 | $1.92M derived: sum of 4 quarters · filed 2026-07-15 |
| 2026-02-28 | $462.71K 10-Q · filed 2026-04-14 | $944.66K derived: sum of 2 quarters · filed 2026-04-14 | $1.48M derived: sum of 3 quarters · filed 2026-04-14 | $2.03M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-11-30 | $481.95K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.02M derived: sum of 2 quarters · filed 2026-02-27 | $1.57M derived: sum of 3 quarters · filed 2026-07-15 | $2.07M 10-K · filed 2026-02-27 |
| 2025-08-31 | $538.22K 10-Q · filed 2025-10-15 | $1.09M derived: sum of 2 quarters · filed 2026-07-15 | $1.58M 10-Q · filed 2025-10-15 | $2.33M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-05-31 | $551.13K 10-Q · filed 2026-07-15 | $1.05M 10-Q · filed 2026-07-15 | $1.79M derived: sum of 3 quarters · filed 2026-07-15 | $2.33M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-02-28 | $494.96K 10-Q · filed 2026-04-14 | $1.24M derived: sum of 2 quarters · filed 2026-04-14 | $1.77M derived: sum of 3 quarters · filed 2026-04-14 | $2.10M derived: sum of 4 quarters · filed 2026-04-14 |
| 2024-11-30 | $745.49K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.28M derived: sum of 2 quarters · filed 2026-02-27 | $1.61M derived: sum of 3 quarters · filed 2026-02-27 | $1.86M 10-K · filed 2026-02-27 |
| 2024-08-31 | $533.46K 10-Q · filed 2025-10-15 | $862.74K derived: sum of 2 quarters · filed 2025-10-15 | $1.12M 10-Q · filed 2025-10-15 | $950.16K derived: sum of 4 quarters · filed 2025-10-15 |
| 2024-05-31 | $329.27K 10-Q · filed 2025-07-15 | $585.73K 10-Q · filed 2025-07-15 | $416.70K derived: sum of 3 quarters · filed 2025-07-15 | $886.34K derived: sum of 4 quarters · filed 2025-07-15 |
| 2024-02-29 | $256.46K 10-Q · filed 2025-04-14 | $87.43K derived: sum of 2 quarters · filed 2025-04-14 | $557.07K derived: sum of 3 quarters · filed 2025-04-14 | |
| 2023-11-30 | -$169.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $300.61K derived: sum of 2 quarters · filed 2025-02-28 | $1.24M 10-K · filed 2025-02-28 | |
| 2023-08-31 | $469.64K 10-Q · filed 2024-10-15 | $1.41M 10-Q · filed 2024-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |